The CEMIP enzyme inhibits the growth of oligodendrocytes and may serve as a therapeutic target to boost myelin repair in MS, ...

Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...

Columnist Ben Hofmeister never feels he's quite ready for the unpredictability of MS, which makes planning for life's challenges hard.

Myelin loss disrupts the coordination of signals between brain regions, impairing the accurate processing of information, ...

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more comfortable is ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

Children with MS who have more paramagnetic rim lesions, or chronic inflammation, tend to show faster declines in brain ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

The symptoms of multiple sclerosis (MS), an autoimmune disease affecting the brain and spinal cord, can vary widely, although patients often experience movement problems, fatigue, pain, vision issues, ...

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...